The document details a Space Ideas Hub event at the University of Leicester focused on medical imaging innovations and business opportunities, emphasizing collaboration between academia and UK industry. It features presentations from various companies highlighting advancements in medical imaging, diagnostic technologies, and regulatory processes for medical products. Attendees are encouraged to engage with the hub for expertise in product development and market strategies.

1. Medical Imaging – Opportunities
for Business
24.01.12
Henry Wellcome Building
University of Leicester
A Space IDEAS Hub Event
In association with:

2. About Space IDEAS Hub
• A knowledge exchange project from the
Space Research Centre of the University of
Leicester
• Feed expertise developed from space
missions into commercial benefit for UK
industry.
• Delivering Innovative Design, Engineering,
Analysis and Support (IDEAS) to your
business.
• Part financed by the European Regional
Development Fund
• UK companies can access and benefit from
our technology and experience.
If your organisation would like to benefit from
our knowledge and expertise, please contact us
at enquiries@spaceideashub.com

3. Session 3b – Developing you Product
and Market
14:45 Two-Minute Company Presentations
Various
15:30 Are you Social?
The place of social media in you marketing and communication
strategy
Paul Dixey
15:50 Benchmarking Countries, Selecting Markets
or Which Countries Should I Export To?
Richard Gilbert
16:20 Closing Remarks
Prof George Fraser

4. Company Presentations
Two Minute Presentations by
Companies

5. Company Presentations
1. CapnaDSP
2. Defect Detection Technologies
3. Diagnostic Imaging Ltd
4. Frazer-Nash Consultancy
5. Medibord Ltd

6. Hardware Acceleration of Algorithms
and Applications >>
• Ultra-high performance Image Processing
• World leader in high performance systems
• Massively parallel compute technology (FPGA, some GPU)
• Rapid prototyping and development
>> CapnaDSP.com
Ultra-high Performance Image Processing

7. 1

8. SmartVent from Diagnostic Imaging Ltd

9. About Frazer-Nash Consultancy
Ian Webb, Engineer
i.webb@fnc.co.uk
Tel: 01306 885050
Web: www.fnc.co.uk
 Who are we?
 Engineers who enjoy tackling difficult problems!
 What do we do?
 Innovative solutions
 Experience across several market sectors
 What can we offer?
 Design
 Analysis
 Project Support
 Systems Engineering
© Frazer-Nash Consultancy Ltd 2012. All rights reserved. SYSTEMS AND ENGINEERING TECHNOLOGY

10. Composites with Clarity™
Medibord® is a ground-breaking MRI, CT and LINACS compatible couch top and
overlay material developed as a direct response to issues with CT and MR image
fusion; resulting in improved radiotherapy planning and treatment.
Medibord® was developed in response to
an existing need to fuse CT and MR scans in
order to improve the treatment of diseases such
as prostate cancer.
Medibord® allows oncologists to position
Patients with repeated precision to facilitate
CT and MR image fusion.
This has enabled NUH oncologists to achieve
their long-term goal of precisely outlining
prostate cancer patient scans.

11. Company Presentations
5. Medical Technologies IKC
6. Midven Ltd
7. Montague Healthcare
9. Panchromos Ltd
10.Plastic Antibodies Ltd

12. Advanced Imaging for Musculoskeletal & Cardiovascular Applications
Diagnostics: Outcomes:
Imaging,
Biosensors, Optical Sensors, Medical Devices &
Bio-Functionalised Microarrays, Regenerative Therapies,
Commercial Adoption,
Devices & Therapies: Clinical Translation
Implantable Materials, Innovation • Accelerated Innovation
Stem Cells, & Knowledge • Reducing Late Failure & Total Costs
• Developing Partnerships &
Biological Scaffolds, Centre Integration of Technologies
Self-Assembling Peptides Increased: Safety, Efficacy
Process Efficiency,
Computer and Experimental Simulation, Regulatory Compliance,
Patient Targeting,
Supporting Trials,
Short Term Prediction of Long Term Outcomes
Viable Reimbursement
Clinical Need / Market Intelligence
Marcus Orton: Technology Innovation Manager – Imaging and Medical Devices
• Contact us: Tel: 0113 3430921 m.a.orton@leeds.ac.uk
• Follow us on Twitter: http://twitter.com/#!/medtechleeds
• Website: www.medical-technologies.co.uk

13. Venture capital funding
Tel: 0121 710 1990
Email: Giovanni.Finocchio@midven.co.uk
Website: www.midven.com

14. Virtual Scanning
1. The light which is absorbed and emitted by proteins is a measure of
the levels of proteins expressed from DNA (genotype) and the rate at
which proteins react with their reactive substrates (phenotype)
[reaction conditions]
A > Proteins
[reaction conditions]
light + Proteins + substrates > Proteins* + metabolites + light
2. The reaction conditions which govern the rate at which a proteins
react (pH, temperature, levels of minerals, levels of cofactors, etc) are
physiologically regulated systems.

15. Product Design & Engineering

16. Plastic Antibodies have advantages over biologic counterparts
Biological Antibodies Plastic Antibodies
Target type Epitopes Small molecules, peptides and proteins
Lead time 26 - 52 weeks 2-4 weeks
Stability Poor High physicochemical stability
Storage Refrigerated or frozen Ambient temperature
Conjugation Established Diverse potential
Copyright © Alacrita LLP 2011 Page | 0 alacrita

17. Company Presentations
9. Q Scientific Consulting
10.Tactiq Ltd
13.Tutela Monitoring Systems
14.Warwick Design

18. Regulatory development of an imaging medicinal
product to Clinical Trial Application
 N Shepherd from Q Scientific Consulting Ltd
 an experienced drug development consultancy: www.qscl.co.uk
 Example: New Chemical Entity (NCE) for local injection
 Development path to the clinical trial, microdose (dose<100µg/subject)
 http://www.mhra.gov.uk/home/groups/l-unit1/documents/websiteresources/con009394.pdf
 Less extensive regulatory requirements
 Need regulatory dossiers: Clinical Trial Application (CTA) ; Investigational
Medicinal Product Dossier (IMPD); Investigator Brochure (IB)
 Need defined quality: for synthesis; pharmacodynamics; product (GMP);
analytical methods (GMP); toxicology package (GLP)
 External costs total ~£105K:
 Drug substance manufacture, product formulation & analysis (£45K)
 Toxicity and mutagenicity package (£30-40K)
 QSCL Project management & Regulatory dossier (£28K)

19. Product Development Consultancy
Applied Intelligence ISO13485 Certified
•Broad medical imaging development experience
Nuclear Medicine PET/CT X-Ray Endoscopy Ophthalmology OCT MRI
Gamma Rays X-Rays Ultraviolet Infrared microwave
10-14 10-12 10-8 10-6 10-4 10-2
• Software, Electronics, User Interfaces and turnkey development
• Regulatory Expertise (ISO 60601, 62304, 62366, 14971, 61508)
• Clients ranging from start-ups to Global corporations like GE Healthcare
• Partnership approach

20.  Wireless Monitoring
 Web Based
 24/7 Alarm Bureau
 Eliminate Compliance Risk
 Release Valuable Resources
 Protect Invaluable Assets
 Deliver Return on Investment
APPLICATIONS
• HOSPITALS AND HEALTHCARE
• BLOOD PLASMA & TISSUE
• BIOTECH & LIFE SCIENCES
• PHARMACY
 Refrigerators • MEDICAL LABORATORIES
Freezers
Cold Rooms • MEDICAL RESEARCH
Stability Chambers
LN2 Chambers Contact
Clean Rooms zadams@tutelamedical.com
Incubators
Ambient Storage Mobile: 07823 322762
The Environment Tel: 01252 406398
www.tutelamedical.com

22. Thank you for your interest
If your organisation would like to benefit from
our knowledge and expertise, please contact us.
Space IDEAS Hub
W: www.spaceideashub.com
E: enquiries@spaceideashub.com
T: 0116 229 7700
Follow us on: